Trevi Therapeutics, Inc. · NASDAQ:TRVI
Viking Global Investors LP's stake in Trevi Therapeutics, Inc. fell to 4.20% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Viking Global Investors LP's stake in Trevi Therapeutics, Inc. fell to 4.20%, 5,128,875 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 5,128,875
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 4.20% | 5,128,875 |
| Viking Global Opportunities Parent GP LLC | 4.20% | 5,128,875 |
| Viking Global Opportunities GP LLC | 2.80% | 3,436,346 |
| Viking Global Opportunities Portfolio GP LLC | 2.80% | 3,436,346 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 2.80% | 3,436,346 |
| Viking Global Opportunities Drawdown GP LLC | 1.40% | 1,692,529 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 1.40% | 1,692,529 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 1.40% | 1,692,529 |
| HALVORSEN OLE ANDREAS | 4.20% | 5,128,875 |
| Ott David C. | 4.20% | 5,128,875 |
| Shabet Rose Sharon | 4.20% | 5,128,875 |
Source
Related
- Trevi Therapeutics, Inc.
- Viking Global Investors LP
- Trevi Therapeutics, Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · Aug 14, 2025
- Schedule 13G/A · Viking Global Investors LP · May 15, 2025
- Form 4 · Heffernan Michael Thomas · Sep 17, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D/A · New Enterprise Associates 16, L.P. · May 7, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026